You just read:

Aragon Pharmaceuticals Secures $42 Million in Series C Financing to Advance Pipeline of Therapies Targeting Hormone-Driven Cancers

News provided by

Aragon Pharmaceuticals

Mar 06, 2012, 07:00 ET